Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 17 November, 2024
Author: Getaka|Social: Getaka Financial Services X (Earlier Twitter) Profile Getaka Financial Services LinkedIn Logo
Stock Ticker - BSE: 530881 | NSE: ABVL

Arunjyoti Bio Ventures Ltd: Intrinsic Value and Fundamental Analysis

Share Price and Basic Stock Data

Last Updated: November 14, 2024, 3:39 pm

Market Cap 257 Cr.
Current Price 138
High / Low164/36.2
Stock P/E114
Book Value 0.95
Dividend Yield0.00 %
ROCE1.85 %
ROE18.0 %
Face Value 10.0
PEG Ratio1.48

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Arunjyoti Bio Ventures Ltd

Competitors of Arunjyoti Bio Ventures Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
IFL Enterprises Ltd 75.0 Cr. 1.003.87/0.95 0.990.00 %5.06 %3.36 % 1.00
Hira Automobile Ltd 19.6 Cr. 71.271.2/26.128.4 51.40.00 %9.65 %5.10 % 10.0
Hindustan Appliances Ltd 344 Cr. 343343/9.832,022 14.50.00 %0.26 %0.90 % 10.0
Hardwyn India Ltd 1,256 Cr. 36.052.0/26.0101 11.10.00 %3.92 %2.58 % 1.00
Grandma Trading & Agencies Ltd 11.8 Cr. 0.903.59/0.80 0.010.00 %0.64 %1.30 % 1.00
Industry Average5,268.76N/A117.42N/AN/A12.238.59N/A

All Competitor Stocks of Arunjyoti Bio Ventures Ltd

Quarterly Result

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Sales2.240.730.000.000.000.000.481.262.803.145.798.7010.10
Expenses2.120.980.020.050.040.020.441.102.743.493.977.466.56
Operating Profit0.12-0.25-0.02-0.05-0.04-0.020.040.160.06-0.351.821.243.54
OPM %5.36%-34.25%8.33%12.70%2.14%-11.15%31.43%14.25%35.05%
Other Income0.000.000.000.280.000.100.000.000.010.070.00-0.040.10
Interest0.000.000.000.000.000.000.00-0.010.010.570.710.800.67
Depreciation0.000.000.000.000.000.000.000.000.000.540.670.810.72
Profit before tax0.12-0.25-0.020.23-0.040.080.040.170.06-1.390.44-0.412.25
Tax %25.00%-12.00%0.00%0.00%0.00%12.50%25.00%0.00%16.67%-0.72%163.64%-407.32%24.89%
Net Profit0.09-0.22-0.020.23-0.040.070.030.170.04-1.37-0.281.261.69
EPS in Rs0.05-0.12-0.010.12-0.020.040.020.090.02-0.74-0.150.680.91

Last Updated: October 7, 2024, 8:37 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: September 23, 2024, 3:00 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales0.070.080.000.2139.270.053.726.745.512.941.7420.4327.73
Expenses0.070.070.020.2739.030.283.686.615.413.141.5717.6521.48
Operating Profit0.000.01-0.02-0.060.24-0.230.040.130.10-0.200.172.786.25
OPM %0.00%12.50%-28.57%0.61%-460.00%1.08%1.93%1.81%-6.80%9.77%13.61%22.54%
Other Income0.010.000.000.000.000.000.000.000.000.280.000.040.13
Interest0.000.000.000.000.000.010.000.000.010.000.012.112.75
Depreciation0.010.010.010.010.000.000.000.000.000.000.002.012.74
Profit before tax0.000.00-0.03-0.070.24-0.240.040.130.090.080.16-1.300.89
Tax %0.00%0.00%16.67%0.00%0.00%23.08%22.22%25.00%25.00%-73.08%
Net Profit0.000.00-0.04-0.070.20-0.250.040.110.070.060.12-0.351.30
EPS in Rs0.000.00-0.02-0.040.11-0.130.020.060.040.030.06-0.190.70
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)-75.00%385.71%-225.00%116.00%175.00%-36.36%-14.29%100.00%-391.67%
Change in YoY Net Profit Growth (%)0.00%460.71%-610.71%341.00%59.00%-211.36%22.08%114.29%-491.67%

Arunjyoti Bio Ventures Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:74%
5 Years:41%
3 Years:55%
TTM:303%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:300%
Stock Price CAGR
10 Years:34%
5 Years:143%
3 Years:285%
1 Year:229%
Return on Equity
10 Years:-1%
5 Years:0%
3 Years:-3%
Last Year:-18%

Last Updated: Unknown

Balance Sheet

Last Updated: Unknown

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Equity Capital2.072.072.072.072.072.072.072.072.072.072.072.07
Reserves-0.19-0.19-0.23-0.30-0.10-0.34-0.30-0.19-0.13-0.070.04-0.30
Borrowings0.000.000.000.040.190.190.000.000.000.0032.2751.41
Other Liabilities0.100.110.130.3617.708.363.714.022.770.091.530.81
Total Liabilities1.981.991.972.1719.8610.285.485.904.712.0935.9153.99
Fixed Assets0.040.030.020.010.000.000.000.000.000.000.0040.50
CWIP0.000.000.000.000.000.000.000.000.000.0019.190.00
Investments0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets1.941.961.952.1619.8610.285.485.904.712.0916.7213.49
Total Assets1.981.991.972.1719.8610.285.485.904.712.0935.9153.99

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +-0.00-0.00-0.00-0.04-0.003.09-2.710.77-0.31-0.78-13.076.31
Cash from Investing Activity +-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-19.19-23.29
Cash from Financing Activity +-0.00-0.00-0.000.040.15-0.00-0.19-0.00-0.00-0.0032.2717.04
Net Cash Flow-0.00-0.00-0.00-0.000.153.09-2.900.77-0.31-0.780.020.06

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow0.000.01-0.02-0.100.05-0.420.040.130.10-0.20-32.10-48.63

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days782.14821.25677.86159.6832,923.00231.56144.59121.8967.04163.6248.77
Inventory Days0.0061.611.802.340.00214.13125.52
Days Payable245.27130.66102.390.0016.71
Cash Conversion Cycle782.14821.25677.86159.6832,923.0047.9015.7321.8467.04377.75157.59
Working Capital Days312.86319.3852.142.14-22,703.00-6.87-40.07-23.85122.91834.89185.27
ROCE %0.00%0.00%-1.61%-3.84%12.09%-11.27%2.17%7.12%5.24%4.06%0.93%1.85%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
Promoters9.10%9.09%9.09%9.09%48.97%48.97%48.97%48.97%48.97%48.97%61.79%61.79%
Public90.90%90.91%90.91%90.90%51.02%51.02%51.03%51.03%51.02%51.02%38.21%38.21%
No. of Shareholders4344414314204525797127037507401,1681,655

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)-1.680.560.270.330.49
Diluted EPS (Rs.)-1.680.560.270.330.49
Cash EPS (Rs.)8.040.560.270.320.49
Book Value[Excl.RevalReserv]/Share (Rs.)8.5310.229.669.399.04
Book Value[Incl.RevalReserv]/Share (Rs.)8.5310.229.669.399.04
Revenue From Operations / Share (Rs.)98.668.3814.3526.6235.29
PBDIT / Share (Rs.)13.550.780.370.450.63
PBIT / Share (Rs.)3.830.780.370.450.63
PBT / Share (Rs.)-6.270.760.360.440.63
Net Profit / Share (Rs.)-1.680.560.270.320.49
PBDIT Margin (%)13.739.382.591.701.79
PBIT Margin (%)3.889.382.591.701.79
PBT Margin (%)-6.359.092.551.671.79
Net Profit Margin (%)-1.706.731.891.231.39
Return on Networth / Equity (%)-19.745.522.813.505.44
Return on Capital Employeed (%)1.700.473.844.826.99
Return On Assets (%)-0.640.322.681.451.73
Long Term Debt / Equity (X)24.9915.260.000.000.00
Total Debt / Equity (X)28.7315.260.000.000.00
Asset Turnover Ratio (%)0.450.090.871.041.28
Current Ratio (X)1.513.6411.671.161.09
Quick Ratio (X)1.113.0611.671.151.09
Inventory Turnover Ratio (X)0.000.00221.570.000.00
Interest Coverage Ratio (X)1.3432.6778.0959.74679.61
Interest Coverage Ratio (Post Tax) (X)0.8324.4358.0444.47530.14
Enterprise Value (Cr.)62.4769.785.170.610.68
EV / Net Operating Revenue (X)3.0640.211.740.110.09
EV / EBITDA (X)22.26428.4567.136.525.22
MarketCap / Net Operating Revenue (X)0.5721.631.740.250.24
Price / BV (X)6.6817.742.590.730.96
Price / Net Operating Revenue (X)0.5721.631.740.250.24
EarningsYield-0.020.000.010.040.05

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Arunjyoti Bio Ventures Ltd as of November 17, 2024 is: 19.88

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 17, 2024, Arunjyoti Bio Ventures Ltd is Overvalued by 85.59% compared to the current share price 138.00

Intrinsic Value of Arunjyoti Bio Ventures Ltd as of November 17, 2024 is: 35.24

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 17, 2024, Arunjyoti Bio Ventures Ltd is Overvalued by 74.46% compared to the current share price 138.00

Last 5 Year EPS CAGR: 77.26%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
    1. The stock has a low average ROCE of 1.40%, which may not be favorable.
    2. The stock has a high average Working Capital Days of 144.73, which may not be favorable.
    3. The stock has a high average Cash Conversion Cycle of 263.40, which may not be favorable.
    4. The company has higher borrowings (7.01) compared to reserves (-0.19), which may suggest financial risk.
    5. The company has not shown consistent growth in sales (8.35) and profit (0.00).

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Arunjyoti Bio Ventures Ltd:
      1. Net Profit Margin: -1.7%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: 1.7% (Industry Average ROCE: 12.23%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: -19.74% (Industry Average ROE: 8.59%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): 0.83
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 1.11
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 114 (Industry average Stock P/E: 117.42)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. Total Debt / Equity: 28.73
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    About the Company - Qualitative Analysis

    Arunjyoti Bio Ventures Ltd. is a Public Limited Listed company incorporated on 27/02/1986 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L01400TG1986PLC062463 and registration number is 062463. Currently Company is involved in the business activities of Wholesale of fertilizers and agrochemical products. Company’s Total Operating Revenue is Rs. 2.97 Cr. and Equity Capital is Rs. 2.07 Cr. for the Year ended 31/03/2022.
    INDUSTRYADDRESSCONTACT
    Trading & DistributorsDoor No.1-98/1/JSIC/6F/604-B, 6th Floor, Jain Sadhguru Capital Park, Madha Telangana 500081cenport@gmail.com
    https://www.abvl.co.in
    Management
    NamePosition Held
    Mr. PBN MurthyWhole Time Director
    Mr. Dathivik PabbathiWhole Time Director
    Mr. Vishal NadimpalliWhole Time Director
    Mrs. Dhanalakshmi GuntakaIndependent Director
    Mr. Srikar RangaIndependent Director
    Mr. Vijaya Rama Lakshmana MurthyIndependent Director

    FAQ

    What is the latest intrinsic value of Arunjyoti Bio Ventures Ltd?

    The latest intrinsic value of Arunjyoti Bio Ventures Ltd as on 17 November 2024 is ₹19.88, which is 85.59% lower than the current market price of ₹138.00.

    What is the Market Cap of Arunjyoti Bio Ventures Ltd?

    The Market Cap of Arunjyoti Bio Ventures Ltd is 257 Cr..

    What is the current Stock Price of Arunjyoti Bio Ventures Ltd as on 17 November 2024?

    The current stock price of Arunjyoti Bio Ventures Ltd as on 17 November 2024 is ₹138.

    What is the High / Low of Arunjyoti Bio Ventures Ltd stocks in FY 2024?

    In FY 2024, the High / Low of Arunjyoti Bio Ventures Ltd stocks is 164/36.2.

    What is the Stock P/E of Arunjyoti Bio Ventures Ltd?

    The Stock P/E of Arunjyoti Bio Ventures Ltd is 114.

    What is the Book Value of Arunjyoti Bio Ventures Ltd?

    The Book Value of Arunjyoti Bio Ventures Ltd is 0.95.

    What is the Dividend Yield of Arunjyoti Bio Ventures Ltd?

    The Dividend Yield of Arunjyoti Bio Ventures Ltd is 0.00 %.

    What is the ROCE of Arunjyoti Bio Ventures Ltd?

    The ROCE of Arunjyoti Bio Ventures Ltd is 1.85 %.

    What is the ROE of Arunjyoti Bio Ventures Ltd?

    The ROE of Arunjyoti Bio Ventures Ltd is 18.0 %.

    What is the Face Value of Arunjyoti Bio Ventures Ltd?

    The Face Value of Arunjyoti Bio Ventures Ltd is 10.0.

    About the Author

    Author Avatar
    Getaka

    Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Arunjyoti Bio Ventures Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE